stockrowHumana Inc.
HUM Healthcare Healthcare Plans
Humana Inc.’s revenue for fiscal 2025 (year ended December 2025) was $129.7 billion, up 10.1% from fiscal 2024.
- Revenue
- +26.1%
- EPS
- −16.7%
- Free cash flow
- +158.7%
- Total debt
- −0.82%
Quarter to September 2026, against a year earlier
Follow HUM
Alert me
Humana Inc. (HUM) Revenue
Humana Inc.'s revenue for fiscal 2025 was $129.7B, up 10.1% from $117.8B in fiscal 2024. Over the twelve months to 30 September 2026 it was $154.2B. Over the past ten years it has ranged from $53.8B (fiscal 2017) to $129.7B (fiscal 2025) — the current reading is the highest in ten years. Revenue has risen for 8 consecutive fiscal years. Humana Inc. ranks 6th of 12 Healthcare Plans companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $129.7B | 10.11% |
| FY2024 | $117.8B | 10.70% |
| FY2023 | $106.4B | 14.54% |
| FY2022 | $92.9B | 11.81% |
| FY2021 | $83.1B | 7.66% |
| FY2020 | $77.2B | 18.90% |
| FY2019 | $64.9B | 14.01% |
| FY2018 | $56.9B | 5.85% |
| FY2017 | $53.8B | (1.13%) |
| FY2016 | $54.4B | 0.17% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $41.2B | 0.70% |
| Jun 2026 | $40.9B | 3.07% |
| Mar 2026 | $39.6B | 21.94% |
| Dec 2025 | $32.5B | (0.41%) |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| UNH UnitedHealth Group Incorporated compare | $449.7B |
| CVS CVS Health Corporation compare | $420.6B |
| CI Cigna Group compare | $286.3B |
| CNC Centene Corporation compare | $203.9B |
| ELV Elevance Health, Inc. compare | $201.8B |
| HUM Humana Inc. | $154.2B |
| MOH Molina Healthcare, Inc compare | $44.1B |
| OSCR Oscar Health, Inc. compare | $17.5B |
| PGNY Progyny, Inc. compare | $1.3B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on HUM
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement